Health Costs

  • Your Selections:

Refine Results

date

Topics

Content Type

Tags

Medicare Part B Drugs: Cost Implications for Beneficiaries in Traditional Medicare and Medicare Advantage

In the face of rising prescription drug costs, a large majority of the public supports federal efforts to lower drug spending. Policymakers are considering several proposals that would lower prescription drug costs. To better understand the potential out-of-pocket cost exposure that Medicare beneficiaries may face for Part B drugs, which are typically administered by physicians and other health care providers, we analyzed cost-sharing liability for these drugs in traditional Medicare and cost-sharing requirements in Medicare Advantage plans.

Issue Brief Read More

Telehealth Continues to Account for More Than a Third of Outpatient Visits for Mental Health and Substance Use Services Well into the COVID-19 Pandemic

A new analysis from KFF and Epic Research finds that telehealth visits for outpatient mental health and substance use services went from virtually zero percent in 2019 prior to the COVID-19 pandemic to a peak of 40% in mid-2020 – and continued to account for more than a third (36%)…

News Release Read More

Telehealth Has Played an Outsized Role Meeting Mental Health Needs During the COVID-19 Pandemic

This analysis from KFF and Epic Research finds that telehealth visits for outpatient mental health and substance use services went from virtually zero percent in 2019 prior to the COVID-19 pandemic to a peak of 40% in mid-2020 – and continued to account for more than a third of such visits in the six months ending in August 2021.

Issue Brief Read More

1 in 10 Adults Owe Medical Debt, With Millions Owing More Than $10,000

Americans Likely Owe Hundreds of Billions of Dollars in Total Medical Debt A new KFF analysis of government data estimates that nearly 1 in 10 adults (9%) – or roughly 23 million people – owe medical debt. This includes 11 million who owe more than $2,000 and 3 million people…

News Release Read More

The Burden of Medical Debt in the United States

This analysis uses government data to examine the burden of medical debt, including variations based on age, race and ethnicity, and health status . It estimates 9% of adults – or roughly 23 million people -owe medical debt, including 11 million who owe more than $2,000.

Issue Brief Read More

How Affordability of Health Care Varies by Income among People with Employer Coverage

This analysis looks at the share of working families’ income that is spent on premiums, deductibles and other cost-sharing for employer-sponsored care. It shows that lower-income families spend a greater share of their income on health costs than those with higher incomes.

Issue Brief Read More

Many households do not have enough money to pay cost-sharing typical in private health plans

This analysis assesses whether people can afford to pay cost-sharing amounts common with private insurance plans. It finds that large shares of non-elderly households do not have enough liquid assets to meet typical plan cost-sharing amounts.

Issue Brief Read More

KFF COVID-19 Vaccine Monitor: The Pandemic’s Toll on Workers and Family Finances During the Omicron Surge

The Vaccine Monitor report examines how families and workers fared financially during the omicron surge. Large shares of workers missed work due to being sick from coronavirus, having to quarantine, or their workplace being closed due to the pandemic. Many, particularly those with lower incomes, report impacts on their family’s finances and stress level.

Poll Finding Read More

4 in 10 Workers – and 6 in 10 of Those with Low Incomes – Say They Missed Work During the Omicron Surge Due to COVID-19 Illness, Quarantine or Closure

The surge in COVID-19 cases triggered by the omicron variant led to widespread work disruptions, with about 4 in 10 workers (42%) – including 6 in 10 of those with lower incomes – saying they had to miss work at least once in the past three months because of a…

News Release Read More

Prices Increased Faster Than Inflation for Half of all Drugs Covered by Medicare in 2020

Recent legislation would require drug companies to pay rebates to the federal government when annual increases in prescription drug prices for Medicare and private insurance exceed the rate of inflation. As context for understanding the possible impact of this proposal, this analysis compares price changes for drugs covered by Medicare Part B (administered by physicians) and Part D (retail prescription drugs) between 2019 and 2020 to the inflation rate over the same period.

Issue Brief Read More

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.